PRAME derived peptides and immunogenic compositions comprising these
US10450356B2 · kind B2 · utility
11Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2016 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Mar 15, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/572
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a peptide having a length of no more than 100 amino acids and comprising at least 19 contiguous amino acids from the amino acid sequence of the human PRAME protein, wherein the peptide comprises at least one HLA class II epitope and at least one HLA class I epitope from the amino acid sequence of the human PRAME protein and to its use as such or in a composition as a medicament for the treatment and/or prevention of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.